from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2191/-

LFCtreatmentdescriptionclass of inhibitor

-0.014

Amikacinug/mL Amikacintranslation

-0.737

Cap5-10ug/mL Capreomycintranslation

-0.730

Rox10-50 ug/mL Roxithromycintranslation

-0.595

SM2-5 ug/mL Streptomycintranslation

-0.019

Tet5-10 ug/mL Tetracyclinetranslation

1.162

Rif0.2-5ug/mL Rifampicintranscription

0.780

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.703

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.046

CPZ10-50 ug/mL Chlorpromazinerespiration

0.387

Clofazimine10-13 ug/mL Clofaziminerespiration

0.028

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.366

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.465

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.070

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.620

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.212

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.255

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.602

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.578

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.899

KCN5-20 ug/mL Potassium cyaniderespiration

0.137

NaN30.2-2 mM Sodium aziderespiration

-0.917

Nigericin50 uM Nigericinrespiration

0.356

TRC10-150 ug/mL Triclosanrespiration

1.011

TRZ10-25 ug/mL Thioridazinerespiration

-1.599

Valinomycin0.5-10 uM Valinomycinrespiration

-1.154

ZnSO42 mM ZnSO4respiration

-0.074

menadione6-10 ug/mL Menadionerespiration

0.568

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.437

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.250

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.606

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.336

NRP_1Non-replicating persistence stage 1dosRassociated

-0.810

Amp0.2mg/mL AmpicillincellWall

-0.241

Cephalexin20-100 ug/mL CephalexincellWall

-0.367

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.030

EMB10-20 ug/mL EthambutolcellWall

-0.699

Eta12-40 ug/mL EthionamidecellWall

-0.445

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.277

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.198

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.209

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.970

BZA0.12 mg/mL BenzamidearomaticAmides

-0.551

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.598

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.066

H2O24 mM hydrogen peroxideDNAdamaging

2.029

Levo10 ug/mL LevofloxacinDNAdamaging

-0.247

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.979

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.280

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.134

UVUV-irradiationDNAdamaging

1.014

ARP41-4 ug/mL Antitubercular compound ARP4?

0.143

Antimycin12.5-50 ug/mL Antimycin A?

-1.021

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.101

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.087

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.421

PA8240.2-2 ug/mL PA-824?

0.277

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.296

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.142

Verapamil50 uM Verapamil?

-0.798

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.129

methoxatin10-20 ug/mL Methoxatin?